A significant advance in cancer research is emerging with the use of VHH fragments to reactivate mutated p53. This crucial malignant protector protein is frequently lost in many types of tumors, resulting uncontrolled https://bookmarkinglog.com/story21985145/mini-antibodies-revive-p53-a-new-approach-for-cancer-management